Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 3, 2010, Pages 179-184

  Chan, Mark Y ^a   Becker, Richard C ^b,c   Sim, Ling Ling ^d   Tan, Virlynn ^d   Lee, Chi Hang ^a,e   Low, Adrian F H ^a,e   Teo, Swee Guan ^a   Ng, Kheng Siang ^f   Tan, Huay Cheem ^a,e   Yeo, Tiong Cheng ^a,e  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d DEPARTMENT OF CARDIOLOGY   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f GLENEAGLES HOSPITAL   (Singapore)

Author keywords

Acute coronary syndrome; Fibrinolysis; Kidney disease; Primary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; THIENOPYRIDINE DERIVATIVE;

ADULT; ARTICLE; CARDIOLOGIST; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; FEMALE; FIBRINOLYTIC THERAPY; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PUBLIC HOSPITAL; REPERFUSION; RISK ASSESSMENT; SINGAPORE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL TIME;

EID: 77950892585     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8.
2. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008;117:296-329.
3. King SB, 3rd, Smith SC, Jr, Hirshfeld JW, Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008;117:261-95.
4. Dragu R, Behar S, Sandach A, Boyko V, Kapeliovich M, Rispler S, et al. Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol 2006;97:1142-55.
5. Medi C, Montalescot G, Budaj A, Fox KA, Lopez-Sendon J, FitzGerald G, et al. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovasc Interv 2009;2: 26-33.
6. Chan MY, Woo KS, Wong HB, Chia BL, Sutandar A, Tan HC. Antecedent risk factors and their control in young patients with a first myocardial infarction. Singapore Med J 2006;47:27-30.
7. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004;44:84-93.
8. Li H, Zhang X, Xu G, Wang X, Zhang C. Determination of reference intervals for creatinine and evaluation of creatinine-based estimating equation for Chinese patients with chronic kidney disease. Clin Chim Acta 2009;403:87-91.
9. Dong X, He M, Song X, Lu B, Yang Y, Zhang S, et al. Performance and comparison of the Cockcroft-Gault and simplified Modification of Diet in Renal Disease formulae in estimating glomerular filtration rate in a Chinese Type 2 diabetic population. Diabet Med 2007;24:1482-6.
10. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol 2007;11:41-50.
11. Gerchman F, Tong J, Utzschneider KM, Hull RL, Zraika S, Udayasankar J, et al. Superiority of the Modification of Diet in Renal Disease equation over the Cockcroft-Gault equation in screening for impaired kidney function in Japanese Americans. Diabetes Res Clin Pract 2007;77:320-6.
12. Ma YC, Zuo L, Zhang CL, Wang M, Wang RF, Wang HY. Comparison of 99mTc-DTPA renal dynamic imaging with modified MDRD equation for glomerular filtration rate estimation in Chinese patients in different stages of chronic kidney disease. Nephrol Dial Transplant 2007;22:417-23.
13. Assali AR, Brosh D, Ben-Dor I, Solodky A, Fuchs S, Teplitsky I, et al. The impact of renal insufficiency on patients' outcomes in emergent angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 2007;69:395-400.
14. Bartorelli AL. Primary angioplasty for acute myocardial infarction--the emerging prognostic role of renal insufficiency. Catheter Cardiovasc Interv 2007;69:401-2.
15. Celik T, Iyisoy A, Yuksel CU, Kilic S, Yilmaz MI, Akgul EO, et al. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction. Coron Artery Dis 2008;19:543-9.
16. Keough-Ryan TM, Kiberd BA, Dipchand CS, Cox JL, Rose CL, Thompson KJ, et al. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia. Am J Kidney Dis 2005;46:845-55.
17. Schiele F, Legalery P, Didier K, Meneveau N, Seronde MF, Caulfield F, et al. Impact of renal dysfunction on 1-year mortality after acute myocardial infarction. Am Heart J 2006;151:661-7.
18. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-70.
19. Yan AT, Yan RT, Tan M, Constance C, Lauzon C, Zaltzman J, et al. Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Can J Cardiol 2006;22:115-20.
20. Lee SH, Kim YJ, Kim W, Park JS, Shin DG, Hur SH, et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J 2008;72:1410-8.
21. Tessone A, Gottlieb S, Barbash IM, Garty M, Porath A, Tenenbaum A, et al. Underuse of standard care and outcome of patients with acute myocardial infarction and chronic renal insufficiency. Cardiology 2007;108:193-9.